Clinical Trial: A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729

U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07811063) titled 'A Study to Test a Single Dose of a New Tablet Formulation of TRTL-729' on Sept. 02.

Brief Summary: This study assesses the safety, tolerability, and pharmacokinetics (PK) of the tablet formulation of TRTL-729 in healthy adults.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: TRTL-729

Participants will receive TRTL-729 tablets.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Tortugas Neuroscience, Inc.

Disclaimer: Curated by HT Syndication....